Related Experiment Video

Updated: Sep 26, 2026

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Left ventricular hypertrophy: virtuous intentions, malign consequences

Saraswati Pokharel1, Umesh C Sharma, Yigal M Pinto

  • 1Department of Cardiology, University of Maastricht, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands.

The International Journal of Biochemistry & Cell Biology
|April 5, 2003
PubMed

Insights

Left ventricular hypertrophy (LVH) involves complex changes in heart structure and function, leading to heart failure. Targeting neuroendocrine activation offers a promising therapeutic strategy for managing LVH progression and improving patient outcomes.

Area of Science:

  • Cardiovascular Research
  • Cardiac Pathophysiology
  • Molecular Cardiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant cardiovascular condition characterized by complex pathophysiology.
  • LVH involves myofilament structural changes, cytoskeletal disorganization, and increased collagen synthesis, contributing to cardiac remodeling and heart failure.
  • Current research emphasizes the role of neuroendocrine activation in LVH progression.

Purpose of the Study:

  • To explore the complex pathophysiology of left ventricular hypertrophy.
  • To evaluate the effectiveness of novel treatment strategies targeting neuroendocrine activation in LVH.
  • To understand the fundamental biology of LVH through treatment evolution.

Main Methods:

  • Review of current cardiovascular research on LVH.
  • Analysis of signal transduction pathways and calcium homeostasis in LVH.
  • Examination of structural changes including myofilaments, cytoskeleton, and collagen synthesis.

Main Results:

  • LVH is associated with progressive left ventricular remodeling and culminates in heart failure.
  • Inhibition of neurohormones is hypothesized to provide long-term benefits in morbidity and mortality for LVH patients.
  • Conventional treatments like diuretics and vasodilators show limited efficacy in reducing LV mass and improving prognosis.

Conclusions:

  • The pathophysiology of LVH is intricate, involving molecular and structural alterations.
  • Therapeutic strategies targeting neuroendocrine pathways represent a promising approach for LVH management.
  • Understanding the biology of LVH through treatment advancements is crucial for improving patient outcomes.

More Related Videos

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice09:40

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Published on: May 13, 2019

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...